对于受限平均生存时间的基线共变量调整方法的比较
Keisuke Hanada1, Junji Moriya1, Masahiro Kojima2
1Biometrics Department, R&D Division, Kyowa Kirin Co., Ltd., Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo.
Contemporary clinical trials
|January 16, 2024
概括
审查权重的反向概率 (IPCW) 方法提供了比伪生存时间更强大的生存分析结果,特别是在各种审查的情况下. 建议IPCW在临床研究中有效处理受审查的数据.
科学领域:
- 生物统计学 生物统计学
- 临床试验 临床试验
- 生存分析的分析.
背景情况:
- 限制平均存活时间 (RMST) 是一种临床测量方法,它避免了对比例危险的假设.
- 我们比较了两个直接建模的生存时间和协变量调整策略.
- 在生存分析中解释伪价值和处理受审查的数据时出现了挑战.
研究的目的:
- 评估伪生存时间的力量和反向概率的审查权重 (IPCW) 方法在检测群体差异.
- 在各种审查场景下比较这两种方法的稳定性和参数估计准确性.
- 根据数据特征和审查模式,为选择合适的方法提供建议.
主要方法:
- 伪存活时间的计算,使用一个离开一个的方法.
- 使用伪值进行共变量调整,结合来自受审查对象的信息.
- 对共变量调整的反向审查权重概率 (IPCW),包括被审查的受试者.
- 计算机模拟以评估方法性能和功率.
- 使用一次性胆道胆炎临床试验数据集进行评估.
主要成果:
- 伪生存时间的解释具有挑战性,并且可能与实际数据相悖,特别是在高度审查的情况下.
- IPCW方法表现出更大的稳定性,受到审查数据平衡的影响较小.
- IPCW保持了名义类型-1错误率,即使在不同群体之间存在不同的审查率和共变量.
- 模拟显示,与伪生存时间相比,IPCW对审查概率的变化不那么敏感.
结论:
- IPCW和伪生存时间方法处理受审查的数据不同,影响参数估计.
- 建议使用IPCW方法,因为它的稳定性和可靠性,特别是当审查概率不同时.
- 当审查概率在各组之间得到平衡时,伪生存时间可能是合适的.
- 选择正确的方法对于准确的生存分析和临床解释至关重要.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Assumptions of Survival Analysis
131
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
131
Kaplan-Meier Approach
146
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
146
Censoring Survival Data
96
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
96
Introduction To Survival Analysis
239
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
239
The Mantel-Cox Log-Rank Test
372
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
372


